Clinical Trials for Psoriasis

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Psoriasis is grouped into the following categories:-

View by trial name

View by drugs used in Psoriasis clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Psoriasis:

Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris - This study is currently recruiting patients (Current: 23 Nov 2006)
Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis - This study is currently recruiting patients (Current: 23 Nov 2006) - Alefacept
Scalp Psoriasis Treatment With a Fiber Optic Comb - This study has been completed (Current: 23 Nov 2006)
Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy - This study has been completed (Current: 23 Nov 2006) - Raptiva (efalizumab)
Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E) Program - This study is currently recruiting patients (Current: 23 Nov 2006)
A Pilot Study of Topical Antiflammin-2 for Psoriasis - This study has been completed (Current: 23 Nov 2006)
Study of Psoriatic Arthritis - This study has been completed (Current: 23 Nov 2006)
A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis - This study has been completed (Current: 23 Nov 2006)
Treatment of Psoriasis Using Acitretin in HIV-Positive Patients - This study has been completed (Current: 23 Nov 2006) - Acitretin
A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients - This study has been completed (Current: 23 Nov 2006) - Zidovudine
Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis - This study has been completed (Current: 23 Nov 2006) - calcitriol
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases - This study has been completed (Current: 23 Nov 2006)
Conditioning, the Placebo Effect, and Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Corticosteroid cream
Study of Topical Calcitriol in Children With Psoriasis - This study has been completed (Current: 23 Nov 2006) - calcitriol
To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris - This study is no longer recruiting patients (Current: 23 Nov 2006) - Daclizumab,Cyclosporine
To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris - This study is no longer recruiting patients (Current: 23 Nov 2006) - Daclizumab
Efficacy and Safety of Infliximab Therapy in Patients With Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Infliximab
A Study of Infliximab in Subjects With Psoriasis - This study has been completed (Current: 23 Nov 2006) - Infliximab
An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis - This study has been completed (Current: 23 Nov 2006) - Etanercept
Enbrel in Psoriatic Arthritis - This study has been completed (Current: 23 Nov 2006) - Enbrel®
A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris - This study is no longer recruiting patients (Current: 23 Nov 2006) - Tetrathiomolybdate (TM)
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Efalizumab
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions - This study is currently recruiting patients (Current: 23 Nov 2006)
Etanercept With Tacrolimus for Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept plus tacrolimus
Transitioning From Cyclosporine to Alefacept in Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Transitioning patients from cyclosporine to alefacept
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Neuroskin Forte and Placebo Application
Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness - This study is no longer recruiting patients (Current: 23 Nov 2006)
Alefacept Mechanism of Action in Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Mechanism of action of alefacept
Bexarotene With Narrow-Band UVB for Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Bexarotene/NBUVB vs placebo NBUVB
Acitretin and Etanercept in Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Patients receiving etanercept will be given acitretin
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept,Methotrexate
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
Study of a New Dressing for Use With Topical Medications - This study is currently recruiting patients (Current: 23 Nov 2006)
Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris - This study is currently recruiting patients (Current: 23 Nov 2006) - Curcuminoids C3 Complex®
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - adalimumab
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
A Long Term Safety Study of Infliximab (Remicade) - This study is no longer recruiting patients (Current: 23 Nov 2006)
A Study of the Safety and Efficacy of CNTO 1275 in Patients With Severe Plaque-Type Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - CNTO 1275
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Tacrolimus Cream
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Tacrolimus Cream
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Tacrolimus
CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. - This study is currently recruiting patients (Current: 23 Nov 2006) - Cyclosporine A versus mycophenolate mofetil for psoriasis
A Study of the Safety and Efficacy of CNTO 1275 in Subjects With Moderate to Severe Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - CNTO 1275
A Study of the Safety and Efficacy of CNTO 1275 in Subjects With Severe Plaque-Type Psoriasis - This study has been completed (Current: 23 Nov 2006) - CNTO 1275
Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis. - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel
Study Evaluating the Safety and Efficacy of Etanercept 50 Mg Once Weekly in Subjects With Psoriasis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Etanercept
Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis - This study has been completed (Current: 23 Nov 2006) - Vehicle (Placebo) applied BID,QRX-101 75 mcg/g ointment applied QD,QRX-101 75 mcg/g ointment applied BID
Cyclosporine in the Pharmacotherapy of Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Cyclosporin
Safety and Efficacy of Topically Applied CTA018 in Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - CTA018 cream
Etanercept (Enbrel) in Psoriasis - Pediatrics - This study is no longer recruiting patients (Current: 23 Nov 2006) - Enbrel®
A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g - This study has been completed (Current: 23 Nov 2006) - Raptiva (efalizumab)
A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet - This study is currently recruiting patients (Current: 23 Nov 2006) - Efalizumab
A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies - This study has been completed (Current: 23 Nov 2006) - efalizumab
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - infliximab
A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g - This study has been completed (Current: 23 Nov 2006) - Raptiva (efalizumab)
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
An Observational Study of the Use and Safety of Raptiva During Pregnancy - This study is currently recruiting patients (Current: 23 Nov 2006)
Efficacy of Re-Treatment With Cimzia in Subject With Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Certolizumab pegol (cimzia®)
Evaluating the Safety of Etanercept 50 Mg Twice Weekly in Subjects With Psoriasis - This study has been completed (Current: 23 Nov 2006) - Etanercept
Long-Term Follow-Up Study of Psoriasis Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - MEDI-507
Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
Role of CD7 in Skin Inflammation and Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
Observational Safety Study of Enbrel for Treatment of Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel
Treatment of Psoriasis With Parathyroid Hormone - This study has been completed (Current: 23 Nov 2006) - Parathyroid hormone ointment
Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - RWJ-445380
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis - This study has been completed (Current: 23 Nov 2006)
Maintenance Effect of Clobex Shampoo on Subjects With Moderate to Severe Scalp Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Clobex Shampoo 0.05%
A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis - This study has been completed (Current: 23 Nov 2006) - Raptiva (efalizumab)
Topical Vitamin B12 in Chronic Plaque Psoriasis - This study has been completed (Current: 23 Nov 2006) - topical vitamin B12
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test - This study is currently recruiting patients (Current: 23 Nov 2006) - Protopic,Advantan
Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy - This study is no longer recruiting patients (Current: 23 Nov 2006) - CDP870 (Certolizumab pegol)
Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis - This study has been completed (Current: 23 Nov 2006)
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles - This study has been completed (Current: 23 Nov 2006)
Micellar Paclitaxel to Treat Severe Psoriasis - This study has been completed (Current: 23 Nov 2006) - Micellar Paclitaxel
Research in Skin Inflammation - This study has been completed (Current: 23 Nov 2006)
A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies - This study has been completed (Current: 23 Nov 2006) - Raptiva (efalizumab)
Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
Study of Etanercept in the Treatment of Psoriasis in Adult Subjects - This study is no longer recruiting patients (Current: 23 Nov 2006) - etanercept
Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - MM-093
Psychiatric Problems in Chronic Skin Diseases - This study has been completed (Current: 23 Nov 2006)
Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - MEDI-507
Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - MEDI-522
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - adalimumab
Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765 - This study is no longer recruiting patients (Current: 23 Nov 2006) - VX-765
Study to Compare Different Light Therapies (Narrowband Ultraviolet B Vs PUVA) for Hand and Foot Skin Diseases. - This study is currently recruiting patients (Current: 23 Nov 2006)
The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists - This study is currently recruiting patients (Current: 23 Nov 2006) - TNF-alpha antagonists
Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - CEP-701
Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis - This study has been completed (Current: 23 Nov 2006) - ISA247
The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2) - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab,methotrexate
Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320) - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab
A 36-Week Extension to Protocol ISA04-03 - This study is no longer recruiting patients (Current: 23 Nov 2006) - ISA247
Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Calcipotriene/betamethasone gel and ointment
Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Anti IL-12 monoclonal antibody/ABT-874/up to 12 weeks
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
Double-Blind, Randomized, Placebo-Controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis - This study has been completed (Current: 23 Nov 2006) - Etanercept
Double-Blind, Randomised, Placebo-Controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
A Study to Evaluate Efalizumab in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent - This study is currently recruiting patients (Current: 23 Nov 2006) - efalizumab
Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks
Genetic Analysis of Psoriasis and Psoriatic Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
Fluphenazine Decanoate for Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Fluphenazine Decanoate
Long-Term Effects of Infliximab in the Treatment of Moderate to Severe Psoriasis [Extension of Study P04271] (P04563) - This study is currently recruiting patients (Current: 23 Nov 2006) - infliximab
Evaluate Whether a Course of Methotrexate in Psoriasis Patients Treated With Efalizumab is Safe and Increases Efficacy - This study is currently recruiting patients (Current: 23 Nov 2006) - Methotrexate,Efalizumab
T Cell Repertoire Analysis of Immune Mediated Skin Diseases - This study is currently recruiting patients (Current: 23 Nov 2006)
Molecular and Cellular Characterization of Spongiotic Dermatitis - This study is not yet open for patient recruitment (Current: 23 Nov 2006)
Effect of Atopic Diathesis as Assessed by Serum Th1/Th2 Cytokine Profile on Clinical Manifestation of Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Pioglitazone
A Phase IIa Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - BMS-582949
Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - efalizumab
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006)
A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis - This study is currently recruiting patients (Current: 23 Nov 2006) - Efalizumab
Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 - This study has been terminated (Current: 23 Nov 2006) - pazopanib (GW786034)
Safety and Tolerability of Repeat Courses of IM Alefacept - This study has been completed (Current: 23 Nov 2006) - Alefacept
Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris - This study is no longer recruiting patients (Current: 23 Nov 2006) - Calcipotriol, (calcipotriol + betamethasone)
This Study Offers Narrowband UVB Light Therapy to Patients With Both Light and Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris. - This study is currently recruiting patients (Current: 23 Nov 2006)
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris - This study is currently recruiting patients (Current: 23 Nov 2006) - Calcipotriol plus betamethasone dipropionate ointment
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris - This study is currently recruiting patients (Current: 23 Nov 2006) - Calcipotriol plus betamethasone dipropionate (LEO 80185) gel
A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris - This study has been completed (Current: 23 Nov 2006) - Abatacept
Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris - This study has been completed (Current: 23 Nov 2006) - CTLA4Ig / Abatacept
Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris - This study is no longer recruiting patients (Current: 23 Nov 2006) - Abatacept
Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Calcipotriol plus betamethasone dipropionate (LEO80185 gel)
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Calcipotriol plus betamethasone dipropionate (LEO80185 gel)
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for Up to a Year in Scalp Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Calcipotriol plus betamethasone dipropionate gel (LEO 80185)
Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Calcipotriol plus betamethasone dipropionate (LEO80185 gel)
Pediatric Open-Label Extension Study - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
A Study of the Safety and Efficacy of Infliximab (Remicade) in Patients With Psoriatic Arthritis - This study has been completed (Current: 23 Nov 2006) - Infliximab
hOKT3gamma1 (Ala-Ala) for the Treatment of Psoriatic Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - hOKT3gamma1 (Ala-Ala)
A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmo-Plantar Pustulosis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Etanercept
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis - This study has been terminated (Current: 23 Nov 2006) - Onercept (r-hTBP-1)
CLEAR Study: Clinical Experience Acquired With Raptiva Study - This study has been completed (Current: 23 Nov 2006) - Raptiva
Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy - This study is no longer recruiting patients (Current: 23 Nov 2006)
Community Based Trial for AMEVIVE - This study is no longer recruiting patients (Current: 23 Nov 2006) - Additional dosing of Alefacept
A Multicentre, Open Label Ph 3b/4 Study of Subcutaneously Admin. Efalizumab (Adult Patients) With Moderate to Severe Chronic Psoriasis Failed to Respond to, or Have a Contraindication to, or Are Intolerant of Other Systemic Therapies Incl. Cyclosporine, Methotrexate and PUVA. - This study is no longer recruiting patients (Current: 23 Nov 2006) - Raptiva (efalizumab - recombinant humanised monoclonal anti-CD11a antibody)
A Multicentre, Open Label Phase IIIb Study of Subcutaneously Administered Raptiva in the Treatment of Adult Patients With Moderate to Severe Plaque Psoriasis - This study is no longer recruiting patients (Current: 23 Nov 2006) - Raptiva (efalizumab - recombinant humanised monoclonal anti-CD11a antibody)
Study of BMS-587101 in Patients With Moderate to Severe Psoriasis - This study has been terminated (Current: 23 Nov 2006) - BMS 587101
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions - This study has been completed (Current: 23 Nov 2006)
Impact of Literacy Level on Patient Education and Health Among People With Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis - This study has been completed (Current: 23 Nov 2006) - efalizumab
Study of Intra-Articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects - This study is currently recruiting patients (Current: 23 Nov 2006)
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Enbrel - This study is currently recruiting patients (Current: 23 Nov 2006) - Enbrel®
TNFalfa Blocking Treatment of Spondylarthropathies - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab,Etanercept,Adalimumab
Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis - This study is no longer recruiting patients (Current: 23 Nov 2006)
Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) - This study is no longer recruiting patients (Current: 23 Nov 2006) - adalimumab
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis - This study is currently recruiting patients (Current: 23 Nov 2006) - Etanercept
A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - Golimumab (CNTO 148)
A Study of the Safety and Efficacy of CNTO 1275 in Patients With Active Psoriatic Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - CNTO 1275, monoclonal antibody to IL-12p40 and IL-23 p40 subunits
Study Evaluating Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - etanercept
Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Nave Disease (RESPOND) (Study P04422) - This study is currently recruiting patients (Current: 23 Nov 2006) - Infliximab + methotrexate vs. methotrexate alone

Drugs used in Clinical Trials for Psoriasis

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Psoriasis: